Cost-Effectiveness of Intensifying Lipid-Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients [Vascular Medicine]

ConclusionsIntensive LLT with statins for all coronary artery disease patients results in the highest overall QALY gain against acceptable costs. However, the number of QALYs gained with intensive LLT by statins in individual patients can be increased with selective benefit‐based treatment.Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifiers: NCT00327691 and NCT00159835

Source: JAHA:Journal of the American Heart Association - February 18, 2017 Category: Cardiology Authors: Stam-Slob, M. C., van der Graaf, Y., Greving, J. P., Dorresteiȷn, J. A. N., Visseren, F. L. J. Tags: Secondary Prevention, Cost-Effectiveness, Quality and Outcomes, Coronary Artery Disease Original Research Source Type: research